Partenaires

IBCP
CNRS UCBL

Logo unite LBTI


Rechercher

Sur ce site

Sur le Web du CNRS


Accueil du site > Equipes > Biologie et Ingénierie du Cartilage (F. Mallein-Gerin) > Thématiques > Caractéristiques de diverses sources de cellules souches mésenchymateuses humaines et leur potentiel à s’engager dans un lignage squelettique > Caractéristiques de diverses sources de cellules souches mésenchymateuses adultes humaines et leur potentiel à s’engager dans un lignage squelettique

Caractéristiques de diverses sources de cellules souches mésenchymateuses adultes humaines et leur potentiel à s’engager dans un lignage squelettique

Project leader  : F. Mallein-Gerin

People involved in the project : J-C. Farges, E. Perrier-Groult, H. Fabre, M. Ducret


The interest in cell therapy and tissue engineering for cartilage repair is increasing and actually, autologous chondrocytes represent the most common source of cells that are transplanted. The use of mesenchymal stem cells (MSC) represents a promising alternative cellular model but satisfactory protocols allowing their chondrogenic conversion together with sufficient cartilage matrix production are still missing. The MSC are found in a variety of tissues and are already used to induce cell differentiation, but with variable efficacy depending on their origin and the lineage considered. Moreover, it is difficult to rank the origin of the MSC in regard of their potential of proliferation and differentiation, from the studies published in the literature. The inter-donor variability and the differences in cell culture conditions used by the research groups hamper a clear identification of subpopulations that could represent precursors of interest for a specific differentiation lineage.

In this context, we have undertaken a comparative flow cytometry analysis of MSC isolated from Wharton’s jelly, adipose tissue, dental pulp, and bone marrow, the gold-standard for MSC (figure 1). An original panel of 27 surface markers has been selected from the literature. The different categories of MSC are cultured in medium without serum, condition allowing more easily their use in clinical application.

Very likely, the co-expression of several markers will allow identification of subpopulations of interest. For instance, we have observed for the first time combined labeling of CD271/CD56/Stro-1, surface markers that are independently proposed as predictive markers for good proliferation, immunosuppression or ability to engage skeletogenesis. We have registered significative differences between the diverse categories of MSC. Such an analysis will be pursued and selected sub-populations will be evaluated for cell proliferation and differentiation, and immunosuppressive properties. Special efforts are made to identify the best source of MSC and culture conditions for efficient chondrogenic differentiation.


Figure 1 : top panel, morphologies of perinatal MSCs were isolated from wharton gely and compared to fibroblasts and articular chondrocytes. Lower panel shows surface markers differentialy expressed by three categories of cells (FACS analyses).


Selected publications :

Ducret M., Fabre H., Farges J.-C., Degoul O., Atzeni G., McGuckin C., Forraz N., Mallein-Gerin F., Perrier-Groult E.
Production of human dental pulp cells with a medicinal manufacturing approach. J. Endod. 2015 ; 41(9):1492-9 doi : 10.1016/j.joen.2015.05.017

Demoor M, Ollitrault D, Gomez-Leduc T, Bouyoucef M, Hervieu M, Fabre H, Lafont J, Denoix JM, Audigié F, Mallein-Gerin F, Legendre F, Galera P. (2014). Cartilage tissue engineering : molecular control of chondrocyte differentiation for proper cartilage matrix reconstruction Biochim Biophys Acta. (general subjects) S0304-4165(14)00091-9


Collaborations :

O. Damour, Laboratoire des Substituts Cutanés et Banque de Tissus et de Cellules, Hôpital Edouard Herriot, Lyon

N. Forraz and C. McGuckin, CTI-BIOTECH, Lyon